Pharmaceuticals: federal contracts ending in the next 12 months
18 Government of Canada contracts in the category Pharmaceuticals worth $982.3M reach their end date in the next year. Current suppliers, values and end dates below.
| Contract | Department | Current supplier | Value | Ends |
|---|---|---|---|---|
| COVID-19 Vaccines | Department of Public Works and Government Services | Moderna Biopharma Canada Corporation | $360.5M | 2027-03-31 |
| COVID-19 Vaccines | Department of Public Works and Government Services | Pfizer Canada ULC | $218.4M | 2027-03-31 |
| MMR, MMRV and Varicella vaccins | Department of Public Works and Government Services | Merck Canada Inc. | $147.5M | 2027-03-31 |
| MMR, MMRV and Varicella vaccins | Department of Public Works and Government Services | GlaxoSmithKline Inc. | $66.1M | 2027-03-31 |
| Anthim | Department of Public Works and Government Services | Elusys Therapeutics, Incorporated | $45.7M | 2027-03-31 |
| Contract (Sanofi) - Supply Pertussis-containing vaccines | Department of Public Works and Government Services | SANOFI PASTEUR LIMITED/SANOFI PASTEUR LIMITEE | $37.8M | 2027-03-31 |
| Contract (GSK) - Supply Pertussis-containing vaccines | Department of Public Works and Government Services | GlaxoSmithKline Inc. | $29.4M | 2027-03-31 |
| Rabies Vaccine - SANOFI PASTEUR LIMITED | Department of Public Works and Government Services | SANOFI PASTEUR LIMITED/SANOFI PASTEUR LIMITEE | $23.9M | 2027-03-31 |
| Rabies Vaccine - Bavarian Nordic A S | Department of Public Works and Government Services | Bavarian Nordic A/S | $17.4M | 2027-03-31 |
| NMSO - Prime Vendor Standing Offer (non-competitive) | Department of Public Works and Government Services | McKesson Canada | $9.6M | 2027-06-30 |
| Hepatitis B Vaccines GSK | Department of Public Works and Government Services | GlaxoSmithKline Inc. | $9.5M | 2027-03-31 |
| Hepatitis B Vaccines Merck | Department of Public Works and Government Services | Merck Canada Inc. | $3.9M | 2027-03-31 |
| Relenza | Department of Public Works and Government Services | GlaxoSmithKline Inc. | $3.6M | 2027-03-31 |
| Meningococcal B Vaccine 2026 - GSK (non-competitive) | Department of Public Works and Government Services | GlaxoSmithKline Inc. | $3.1M | 2027-03-31 |
| TB Drugs 2024 - Pharmascience Inc. (non-competitive) | Department of Public Works and Government Services | Pharmascience Inc. | $2.8M | 2027-06-30 |
| Contract Oseltamivir capsules | Department of Public Works and Government Services | SANDOZ CANADA INC. | $2.7M | 2027-03-31 |
| Rabies Immunoglobulin (RIG) | Department of Public Works and Government Services | Grifols Canada Ltd | $396,724 | 2027-03-31 |
| 6D024-225363 - Ebola Vaccine (PR6291) (non-competitive) | Department of Public Works and Government Services | Merck Canada Inc. | $214,800 | 2027-03-31 |
Showing the 18 largest contracts over $25,000. The full list, with extension options and possible re-tenders, is below or through the TenderTrail API.
Get all 18 contracts as a spreadsheet
Every contract ending in the next 12 months, with the current supplier, value, end date, the extension options stated in the notice and any open tender that may be its re-tender. Download as Excel, CSV or JSON.
Get the list on Apify → Pay by card. About $1 USD (1 cent per contract).
On Apify choose Contracts ending soon, set Category to Pharmaceuticals, and set Max results to 18.
Weekly email digest: coming soon
A weekly email of contracts ending in your categories, with the incumbent, value, end date and whether the notice states extension options. Until it opens, the full data (including extension options and possible re-tenders) is available through the TenderTrail API.